temozolomide has been researched along with glutaminase in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M; Kato, K; Kato, Y; Motomura, A; Motomura, K; Natsume, A; Ohka, F; Ranjit, M; Saito, K; Senga, T; Soga, T; Wakabayashi, T | 1 |
| Chang, X; Lian, S; Zhang, H; Zhu, W | 1 |
| Bai, R; Bi, H; Liu, Y; Luo, J; Qu, C; Shi, X | 1 |
3 other study(ies) available for temozolomide and glutaminase
| Article | Year |
|---|---|
Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation.
Topics: Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Glioma; Glutaminase; Glutamine; Glutarates; HEK293 Cells; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Metabolome; Mutation; Temozolomide | 2014 |
Sensitization of melanoma cells to temozolomide by overexpression of microRNA 203 through direct targeting of glutaminase-mediated glutamine metabolism.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Dacarbazine; Down-Regulation; Drug Resistance, Neoplasm; Glutaminase; Glutamine; Humans; Melanoma; MicroRNAs; Temozolomide | 2017 |
Long non-coding RNA ATXN8OS promotes ferroptosis and inhibits the temozolomide-resistance of gliomas through the ADAR/GLS2 pathway.
Topics: Adenosine Deaminase; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Ferroptosis; Glioma; Glutaminase; Humans; RNA-Binding Proteins; RNA, Long Noncoding; Temozolomide | 2022 |